ArticleGeroScience2026
Interaction of moderate-to-vigorous physical activity and brain amyloid accumulation on longitudinal cognitive change.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Amyloid β (Aβ)-related cognitive decline is a key target for dementia prevention; however, the intensity-dependent modifying role of physical activity remains unclear. We investigated whether moderate-to-vigorous physical activity (MVPA) and walking activity attenuate Aβ-related cognitive decline. This cohort study included 74 community-dwelling older adults who underwent Aβ positron emission tomography and repeated cognitive assessments using the Mini-Mental State Examination (mean interval = 23.6 ± 0.9 months). Aβ positivity was defined as a global standardized uptake value ratio > 1.10. Physical activity was assessed with the International Physical Activity Questionnaire-Short Form. MVPA time was categorized using the World Health Organization threshold (≥ 150 min/week), and walking time was dichotomized at the median. Linear mixed-effects models tested three-way interactions among time, Aβ status, and physical activity, adjusting for age, sex, and education. The mean age was 72.7 ± 5.5 years and 44.6% were women; 18 participants (24.3%) were Aβ positive. Aβ positivity was associated with greater cognitive decline among participants with lower MVPA, whereas little or no decline was observed among those with higher MVPA (β for Time × Aβ × MVPA interaction = - 3.30; 95% CI, - 6.35 to - 0.25; p = 0.034). No significant interaction was observed for walking activity (β for Time × Aβ × Walking interaction = 1.43; 95% CI, - 1.48 to 4.35; p = 0.331). Higher MVPA was associated with less pronounced Aβ-related cognitive decline, suggesting an intensity-dependent effect of physical activity. These findings support the cognitive benefits of MVPA in the context of cerebral amyloid burden.
Indexed as
Identifiers
42185590What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.